Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients
about
Proteomics and systems biology: current and future applications in the nutritional sciencesConcurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients.Biomarker discovery and redundancy reduction towards classification using a multi-factorial MALDI-TOF MS T2DM mouse model dataset.Identification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes.Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3.Label-free profiling of white adipose tissue of rats exhibiting high or low levels of intrinsic exercise capacity.Proteomic profiling for peritoneal dialysate: differential protein expression in diabetes mellitusA proteomic approach to identification of plutonium-binding proteins in mammalian cellsProteome-base biomarkers in diabetes mellitus: progress on biofluids' protein profiling using mass spectrometry.Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory functionCharacterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.Getting too sweet: galectin-1 dysregulation in gestational diabetes mellitusIncreased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker
P2860
Q26829598-604141A8-6CCC-45F9-8846-7E6C0E5DE2FFQ33872738-14BBA95C-440D-4301-97AB-DFA12B643597Q33893305-3C4221D8-0669-4AE5-AC32-248532C16BD5Q34078908-C83A7828-F613-4D1B-8B8B-BF7A2EB816E1Q35553234-51D9CD83-6C0A-42EF-9953-3D9FE82BE9E0Q35845602-766AC860-4372-4572-B6A4-502A5D8F62E3Q36921734-38371043-1DE9-45C6-99DA-E5D9D5828F1DQ36944589-F846DCD8-5B37-46F0-91B4-04E1B1EF84A0Q38045278-E67FDE82-C5CC-4E21-9572-37E522260402Q38317758-D0A74EC5-5D88-4D4E-BCBC-291DCCDF173DQ38619939-D0F0948B-5A10-4B0B-9F19-3A75EC8B8EAEQ41130687-67568C2D-854B-45EC-8E7D-8B556389810BQ56957240-F0472D3C-0F8C-4B32-BC0F-EBF4E48E53D4Q58779449-4E7D031F-4CAD-491C-9417-9F2BB4AB2528
P2860
Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients
description
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im März 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/03/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/03/01)
@nl
наукова стаття, опублікована в березні 2009
@uk
مقالة علمية (نشرت في مارس 2009)
@ar
name
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@ast
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@en
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@nl
type
label
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@ast
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@en
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@nl
prefLabel
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@ast
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@en
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@nl
P2093
P356
P1476
Proteomics-based identificatio ...... ma of type 2 diabetic patients
@en
P2093
Qiping Feng
Xiaojun Liu
Yongsheng Chang
P304
P356
10.1021/PR800850A
P577
2009-03-01T00:00:00Z